H

Hana Pharm Co Ltd
KRX:293480

Watchlist Manager
Hana Pharm Co Ltd
KRX:293480
Watchlist
Price: 10 380 KRW -0.1% Market Closed
Market Cap: 184.5B KRW
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

0
Revenue
+0%
Growth Rates:
1 Year
+0%
3 Years
+15%
5 Years
+35%
7 Years
-
10 Years
-
0
Operating Income
+0%
Growth Rates:
1 Year
-7%
3 Years
-30%
5 Years
-25%
7 Years
-
10 Years
-
0
Net Income
+0%
Growth Rates:
1 Year
-5%
3 Years
-24%
5 Years
-25%
7 Years
-
10 Years
-

Earnings Waterfall
Hana Pharm Co Ltd

Revenue
225.3B KRW
Cost of Revenue
-84B KRW
Gross Profit
141.3B KRW
Operating Expenses
-116.1B KRW
Operating Income
25.2B KRW
Other Expenses
-3.9B KRW
Net Income
21.3B KRW

Income Statement
Hana Pharm Co Ltd

Rotate your device to view
Income Statement
Currency: KRW
Millions
Ones
Thousands
Millions
Billions
TTM
Quarterly
Annual
TTM
Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024
Revenue
Revenue
147 137
N/A
145 999
-1%
152 833
+5%
156 766
+3%
159 379
+2%
163 384
+3%
166 347
+2%
168 322
+1%
169 060
+0%
172 619
+2%
177 306
+3%
180 041
+2%
186 792
+4%
191 424
+2%
196 407
+3%
202 631
+3%
205 176
+1%
209 975
+2%
210 845
+0%
214 229
+2%
220 494
+3%
221 575
+0%
224 457
+1%
227 413
+1%
223 549
-2%
225 193
+1%
225 340
+0%
Gross Profit
Cost of Revenue
(47 322)
(45 940)
(50 926)
(52 344)
(53 375)
(54 809)
(56 150)
(57 860)
(58 901)
(61 279)
(63 283)
(63 159)
(64 987)
(65 182)
(65 589)
(69 735)
(72 511)
(77 502)
(79 605)
(81 031)
(82 841)
(82 823)
(84 872)
(85 796)
(83 801)
(86 662)
(84 048)
Gross Profit
99 815
N/A
100 059
+0%
101 907
+2%
104 422
+2%
106 005
+2%
108 576
+2%
110 197
+1%
110 462
+0%
110 157
0%
111 338
+1%
114 023
+2%
116 881
+3%
121 805
+4%
126 243
+4%
130 818
+4%
132 896
+2%
132 666
0%
132 473
0%
131 240
-1%
133 198
+1%
137 653
+3%
138 752
+1%
139 584
+1%
141 617
+1%
139 747
-1%
138 531
-1%
141 292
+2%
Operating Income
Operating Expenses
(66 538)
(67 256)
(68 344)
(70 509)
(72 978)
(75 356)
(76 631)
(78 017)
(78 596)
(79 336)
(82 348)
(85 957)
(87 182)
(92 810)
(94 808)
(94 520)
(97 570)
(97 914)
(100 069)
(103 120)
(106 264)
(109 507)
(112 553)
(113 796)
(115 997)
(116 458)
(116 138)
Selling, General & Administrative
(64 768)
(66 190)
(65 463)
(69 515)
(70 180)
(71 645)
(72 553)
(73 182)
(73 622)
(74 150)
(76 908)
(80 724)
(81 288)
(86 711)
(88 293)
(87 848)
(90 362)
(90 146)
(91 824)
(93 656)
(96 497)
(99 041)
(101 505)
(103 205)
(104 946)
(104 318)
(103 603)
Research & Development
0
0
(2 191)
(1 036)
(1 862)
(2 431)
(2 562)
(2 795)
(2 982)
(3 142)
(3 242)
(3 303)
(3 303)
(3 320)
(3 489)
(3 663)
(3 983)
(4 413)
(4 748)
(5 860)
(6 171)
(6 853)
(7 404)
(6 966)
(7 392)
(8 508)
(8 984)
Depreciation & Amortization
0
0
(690)
(478)
(787)
(1 131)
(1 515)
(1 761)
(1 992)
(2 146)
(2 197)
(2 481)
(2 592)
(2 862)
(3 026)
(3 009)
(3 224)
(3 355)
(3 497)
(3 560)
(3 575)
(3 613)
(3 644)
(3 666)
(3 700)
(3 632)
(3 550)
Other Operating Expenses
(1 770)
(1 066)
0
520
(149)
(149)
0
(279)
0
102
0
551
0
83
0
0
0
0
0
(44)
(21)
0
0
41
41
0
0
Operating Income
33 276
N/A
32 802
-1%
33 563
+2%
33 913
+1%
33 027
-3%
33 220
+1%
33 566
+1%
32 446
-3%
31 562
-3%
32 003
+1%
31 675
-1%
30 923
-2%
34 622
+12%
33 433
-3%
36 010
+8%
38 377
+7%
35 096
-9%
34 559
-2%
31 171
-10%
30 078
-4%
31 389
+4%
29 245
-7%
27 031
-8%
27 822
+3%
23 750
-15%
22 073
-7%
25 154
+14%
Pre-Tax Income
Interest Income Expense
(899)
(659)
100
1 017
1 791
2 303
2 101
1 685
1 476
1 265
1 131
1 012
998
822
695
682
507
(174)
(188)
(473)
(51)
339
834
1 210
1 536
1 806
1 195
Non-Reccuring Items
0
0
(147)
0
0
0
(279)
0
101
0
170
0
83
0
0
0
64
65
(44)
0
0
(32)
41
0
0
44
(8)
Gain/Loss on Disposition of Assets
0
0
41
0
16
38
37
53
62
166
544
544
839
982
27
20
(275)
(653)
(104)
(115)
(121)
(5)
(16)
20
37
35
37
Total Other Income
(1 333)
(1 328)
(1 225)
(1 158)
(323)
(337)
(563)
(531)
(786)
(1 064)
(5 025)
(5 353)
(5 339)
(5 939)
(885)
(996)
(876)
259
(116)
2
98
(415)
17
(135)
265
495
(984)
Pre-Tax Income
31 044
N/A
30 813
-1%
32 332
+5%
33 773
+4%
34 511
+2%
35 226
+2%
34 862
-1%
33 653
-3%
32 415
-4%
32 368
0%
28 495
-12%
27 125
-5%
31 203
+15%
29 299
-6%
35 847
+22%
38 082
+6%
34 515
-9%
34 055
-1%
30 718
-10%
29 492
-4%
31 316
+6%
29 132
-7%
27 907
-4%
28 917
+4%
25 589
-12%
24 454
-4%
25 394
+4%
Net Income
Tax Provision
(6 271)
(6 510)
(6 163)
(6 412)
(5 935)
(5 878)
(6 558)
(6 528)
(7 197)
(6 419)
(13 603)
(13 335)
(13 898)
(12 562)
(7 833)
(8 433)
(7 713)
(9 529)
(6 411)
(5 970)
(5 947)
(5 405)
(5 574)
(5 820)
(5 171)
(4 908)
(4 144)
Income from Continuing Operations
24 773
24 303
26 169
27 361
28 575
29 346
28 304
27 123
25 218
25 950
14 893
13 791
17 305
16 737
28 014
29 650
26 802
24 526
24 307
23 522
25 369
23 726
22 333
23 097
20 417
19 545
21 250
Income to Minority Interest
2
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Income (Common)
24 775
N/A
24 304
-2%
26 170
+8%
27 362
+5%
28 576
+4%
29 346
+3%
28 304
-4%
27 123
-4%
25 218
-7%
25 950
+3%
14 893
-43%
13 791
-7%
17 305
+25%
16 737
-3%
28 014
+67%
29 650
+6%
26 802
-10%
24 526
-8%
24 307
-1%
23 522
-3%
25 369
+8%
23 726
-6%
22 333
-6%
23 097
+3%
20 417
-12%
19 545
-4%
21 250
+9%
EPS (Diluted)
1 769.64
N/A
1 736
-2%
1 744.66
+0%
1 520.11
-13%
1 587.55
+4%
1 726.23
+9%
1 572.44
-9%
1 595.47
+1%
1 483.41
-7%
1 526.47
+3%
860.74
-44%
797.06
-7%
1 056.12
+33%
967.48
-8%
1 679.05
+74%
1 713.9
+2%
1 549.28
-10%
1 417.7
-8%
1 405.08
-1%
1 359.68
-3%
1 466.45
+8%
1 371.49
-6%
1 290.95
-6%
1 335.11
+3%
1 180.22
-12%
1 129.82
-4%
1 228.36
+9%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 242,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.